What the buyer wrote
A framework that will inform recommendations to ministers on the procurement and manufacture of drugs for the treatment of COVID-19, potentially incurring significant expenditure at risk. This decision-making framework will be used alongside the clinical expertise already available to the department such as the Chief Medical Officer (CMO) and Deputy Chief Medical Officer's (DCMO) assessment of treatments data.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Promising treatments decision maker
- How they are buying
- Advertised, shortlist firstSuppliers applied to be considered, and the buyer picked who went on to bid.
- Type
- services
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 2 Jun 2020
- Work ends
- 30 Jun 2020
- Kind of work
- Health and social care
Who the buyer named
The buyer published a contact address on this notice.